Björn Cochlovius

Björn Cochlovius, Ph.D., is the CEO of eleva GmbH and founder of BC BioMed Consulting GmbH, focusing on supporting biotech companies in strategy, partnering, M&A, and fundraising. They hold the position of Associate Professor of Immunology at Ruprecht-Karls Universität Heidelberg Medical Faculty, where they teach medical students. Throughout their career, they have contributed significantly to corporate development in the biotech and pharmaceutical sectors, including roles at AbbVie, Otsuka, and Roche Pharmaceuticals. Björn also holds multiple leadership positions on various boards, demonstrating extensive experience in the industry. They earned their Ph.D. in Oncology, Immunology, and Molecular Biology from Universität des Saarlandes.